Research Article| Volume 26, ISSUE 12, P2988-2993, December 2017

Download started.


Right Heart Failure as a Risk for Stroke in Patients with Chronic Obstructive Pulmonary Disease: A Case-Control Study


      Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory condition characterized by complex lesions of the lungs and other organs as well as a progressive obstruction of the airway. In COPD patients, heart failure (HF) is associated with worse conditions such as inflammation, arterial stiffness, and increased risk mortality. However, the association of HF, COPD, and stroke are unclear; the examination of the role of HF, especially right HF, about increased risk of stroke in COPD patients has not been studied. We aimed to determine if right HF is a risk factor for stroke in patients with COPD.

      Materials and methods

      A case-control study of patients with COPD was carried out. The cases were defined as COPD patients with ischemic stroke and control COPD patients without stroke.


      A total of 162 patients with COPD were analyzed: COPD with stroke (n = 35) and COPD alone (n = 127). COPD patients with right HF were at a greater risk of stroke compared with patients without right HF (odds ratio 3.03, 95% confidence interval 1.13-10.12, p = .044) adjusted for confounding factors.


      Right HF is an independent risk factor for stroke, probably because of cerebrovascular stasis secondary to congestion of the superior vena cava.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Halbert R.J.
        • Natoli J.L.
        • Gano A.
        • et al.
        Global burden of COPD: systematic review and meta-analysis.
        Eur Respir J. 2006; 28: 523-532
        • Agusti A.
        • Calverley P.M.A.
        • Celli B.
        • et al.
        Characterisation of COPD heterogeneity in the ECLIPSE cohort.
        Respir Res. 2010; 11: 122
        • Han M.K.
        • Agusti A.
        • Calverley P.M.
        • et al.
        Chronic obstructive pulmonary disease phenotypes: the future of COPD.
        Am J Respir Crit Care Med. 2010; 182: 598-604
        • Lozano R.
        • Naghavi M.
        • Foreman K.
        • et al.
        Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
        Lancet. 2012; 380: 2095-2128
        • Austin V.
        • Crack P.J.
        • Bozinovski S.
        • et al.
        COPD and stroke: are systemic inflammation and oxidative stress the missing links?.
        Clin Sci. 2016; 130: 1039-1050
        • Sin D.D.
        • Man S.F.P.
        Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality.
        Proc Am Thorac Soc. 2005; 2: 8-11
        • Fabbri L.M.
        • Rabe K.F.
        From COPD to chronic systemic inflammatory syndrome?.
        Lancet. 2007; 370: 797-799
        • Patel A.R.C.
        • Kowlessar B.S.
        • Donaldson G.C.
        • et al.
        Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2013; 188: 1091-1099
        • Aryal S.D.-G.S.
        • Mannino D.M.
        Epidemiology of comorbidities in chronic obstructive pulmonary disease: clusters, phenotypes and outcomes.
        Ital J Med. 2012; 6: 276-284
        • Sidney S.
        • Sorel M.
        • Quesenberry C.P.
        • et al.
        COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.
        Chest. 2005; 128: 2068-2075
        • Rodríguez L.A.G.
        • Wallander M.-A.
        • Martín-Merino E.
        • et al.
        Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study.
        Respir Med. 2010; 104: 1691-1699
        • Boudestein L.C.M.
        • Rutten F.H.
        • Cramer M.J.
        • et al.
        The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease.
        Eur J Heart Fail. 2009; 11: 1182-1188
        • Libby P.
        • Ridker P.M.
        • Maseri A.
        Inflammation and atherosclerosis.
        Circulation. 2002; 105: 1135-1143
        • Chang C.
        • Yao W.
        Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease.
        Med Sci Monit. 2014; 20: 311-320
        • Naeije R.
        Pulmonary hypertension and right heart failure in COPD.
        Monaldi Arch Chest Dis. 2003; 59: 250-253
        • Naeije R.
        Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease.
        Proc Am Thorac Soc. 2005; 2: 20-22
        • Sabit R.
        • Bolton C.E.
        • Edwards P.H.
        • et al.
        Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2007; 175: 1259-1265
        • Sabit R.
        • Bolton C.E.
        • Fraser A.G.
        • et al.
        Sub-clinical left and right ventricular dysfunction in patients with COPD.
        Respir Med. 2010; 104: 1171-1178
        • Wannamethee S.G.
        • Shaper A.G.
        • Ebrahim S.
        Respiratory function and risk of stroke.
        Stroke. 1995; 26: 2004-2010
        • Gulsvik A.K.
        • Gulsvik A.
        • Skovlund E.
        • et al.
        The association between lung function and fatal stroke in a community followed for 4 decades.
        J Epidemiol Community Health. 2012; 66: 1030-1036
        • Perera W.R.
        • Hurst J.R.
        • Wilkinson T.M.A.
        • et al.
        Inflammatory changes, recovery and recurrence at COPD exacerbation.
        Eur Respir J. 2007; 29: 527-534
        • Vestbo J.
        • Hurd S.S.
        • Agustí A.G.
        • et al.
        Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
        Am J Respir Crit Care Med. 2013; 187: 347-365
        • Ponikowski P.
        • Voors A.A.
        • Anker S.D.
        • et al.
        2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
        Eur J Heart Fail. 2016; 18: 891-975
        • Curkendall S.M.
        • DeLuise C.
        • Jones J.K.
        • et al.
        Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.
        Ann Epidemiol. 2006; 16: 63-70
        • Finkelstein J.
        • Cha E.
        • Scharf S.M.
        Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.
        Int J Chron Obstruct Pulmon Dis. 2009; 4: 337-349
        • Schneider C.
        • Bothner U.
        • Jick S.S.
        • et al.
        Chronic obstructive pulmonary disease and the risk of cardiovascular diseases.
        Eur J Epidemiol. 2010; 25: 253-260
        • Hofman A.
        • Darwish Murad S.
        • van Duijn C.M.
        • et al.
        The Rotterdam Study: 2014 objectives and design update.
        Eur J Epidemiol. 2013; 28: 889-926
        • Lahousse L.
        • Vernooij M.W.
        • Darweesh S.K.L.
        • et al.
        Chronic obstructive pulmonary disease and cerebral microbleeds. The Rotterdam Study.
        Am J Respir Crit Care Med. 2013; 188: 783-788
        • Muir K.W.
        • Tyrrell P.
        • Sattar N.
        • et al.
        Inflammation and ischaemic stroke.
        Curr Opin Neurol. 2007; 20: 334-342
        • Feary J.R.
        • Rodrigues L.C.
        • Smith C.J.
        • et al.
        Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.
        Thorax. 2010; 65: 956-962
        • Foster G.E.
        • Brugniaux J.V.
        • Pialoux V.
        • et al.
        Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans.
        J Physiol. 2009; 587: 3287-3299
        • Donaldson G.C.
        • Hurst J.R.
        • Smith C.J.
        • et al.
        Increased risk of myocardial infarction and stroke following exacerbation of COPD.
        Chest. 2010; 137: 1091-1097
        • Go A.S.
        • Mozaffarian D.
        • Roger V.L.
        • et al.
        Heart disease and stroke statistics—2014 update: a report from the American Heart Association.
        Circulation. 2014; 129: e28-e292
        • Portegies M.L.P.
        • Lahousse L.
        • Joos G.F.
        • et al.
        Chronic obstructive pulmonary disease and the risk of stroke. The Rotterdam Study.
        Am J Respir Crit Care Med. 2016; 193: 251-258
        • Kavousi M.
        • Elias-Smale S.
        • Rutten J.H.W.
        • et al.
        Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.
        Ann Intern Med. 2012; 156: 438-444
        • Bamford J.
        • Sandercock P.
        • Dennis M.
        • et al.
        Classification and natural history of clinically identifiable subtypes of cerebral infarction.
        Lancet. 1991; 337: 1521-1526
        • Adams H.P.
        • Bendixen B.H.
        • Kappelle L.J.
        • et al.
        Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
        Stroke. 1993; 24: 35-41
        • Macchia A.
        • Rodriguez Moncalvo J.J.
        • Kleinert M.
        • et al.
        Unrecognised ventricular dysfunction in COPD.
        Eur Respir J. 2012; 39: 51-58